This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Policy

InOncology.com

Connect with Us

It's about making the connections that count. 

Boehringer Ingelheim are always looking for new collaborations and to hear your feedback, please get in touch below. 

inOncology.com

inOncology.com is a point-of-view–driven medical education website designed to support healthcare professionals (HCPs) in their clinical practice and career. Created by Boehringer Ingelheim, inOncology.com seeks to provide HCPs not only with clinical information but also independent expert opinions to help provide context as well as extensive downloadable resources for continued development.

Boehringer Ingelheim

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Since our foundation in 1885, we have been a family-owned company that believes in evidence-based scientific progress. Working in close collaboration with the international scientific community and some of the world’s leading cancer centres, we have embarked on a major research programme to develop innovative cancer medicines. Our extensive oncology clinical trial programme involves more than 800 study centres in 47 countries and works to ensure that studies with our compounds provide the data that will form a solid basis for your informed decision. We are committed to an €11 billion investment in our 5-year research and development (R&D) programme until 2020, demonstrating a clear commitment to the health of current generations and many to come.